White matter hyperintensities, cerebrospinal amyloid-β and dementia in Parkinson's disease

J Neurol Sci. 2016 Aug 15:367:284-90. doi: 10.1016/j.jns.2016.06.009. Epub 2016 Jun 11.
No abstract available

Keywords: Amyloid-β; Cerebrospinal fluid; Dementia; Parkinson's disease; White matter hyperintensities.

MeSH terms

  • Aged
  • Amyloid beta-Peptides / cerebrospinal fluid*
  • Apolipoproteins E / genetics
  • Biomarkers / cerebrospinal fluid
  • Brain / diagnostic imaging
  • Case-Control Studies
  • Cross-Sectional Studies
  • Dementia / cerebrospinal fluid*
  • Dementia / complications
  • Dementia / diagnostic imaging*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Follow-Up Studies
  • Humans
  • Longitudinal Studies
  • Magnetic Resonance Imaging
  • Male
  • Mental Status Schedule
  • Parkinson Disease / cerebrospinal fluid*
  • Parkinson Disease / complications
  • Parkinson Disease / diagnostic imaging*
  • Parkinson Disease / psychology
  • Peptide Fragments / cerebrospinal fluid*
  • Prospective Studies
  • Risk
  • White Matter / diagnostic imaging*
  • alpha-Synuclein / cerebrospinal fluid

Substances

  • Amyloid beta-Peptides
  • Apolipoproteins E
  • Biomarkers
  • Peptide Fragments
  • SNCA protein, human
  • alpha-Synuclein
  • amyloid beta-protein (1-42)